WHO Seminar spotlights medical products control
In October 2015, the “Region of the Americas Workshop on Surveillance and Monitoring of substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products,” organized by the World Health Organization (WHO) was held in Buenos Aires.
Representatives of the health authorities of 22 American countries attended the event, which was aimed at advancing on the implementation of the “WHO Surveillance and Rapid Alert System for SSFFC Medical Products.”
The long-term goal of this project is to significantly improve the quantity, quality and analysis of data on the incidence of SSFFC medical products through the creation of a global surveillance and monitoring system. National health authorities are being trained by WHO to report incidents involving SSFFC to the new system through the use of a WHO Rapid Alert Form.
The Alert System was presented by the WHO consultants Michael Deats and Pernette Bourdillon, together with regional advisers Analia Porras, Jose Luis Castro and Edgar Rojas. The participants discussed the capabilities of the tool, as well as its advantagesto fight this worldwide public health problem.
During his presentation, Deats stated that “the movement of drugs and the ingredients contained therein have a global nature. Therefore, we need surveillance systems that are also global in order to spot the problem at the moment it is happening.”